Shanghai Zhongke New Life Biological Technology

Provider of sequencing and bioinformatics services. The company provides services such as high-throughput sequencing, proteomics, PTM modification, metabolomics, post-translational modification group, metabolite, biomedical structure characterization services, and bioinformatics services. Founded in 2003, headquartered in Shanghai, China. The company has raised $28.3M in funding at the series c stage. The team comprises 44 (Jun 30, 2026) employees. The company operates in the Life Sciences Platforms and Tools sector with additional focus on Genomics. Its business model centers on Bioinformatics. Founded in 2003, headquartered in Shanghai, China. The company has raised $28.3M at the Series C stage. Backed by investors including Luxin Venture Capital Group, Daan Financial Holding Group, GF Xinde Investment Management, Shanghai Shengshi Capital Management, Legend Capital and others.